<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Micro Contact Solution on Korea Invest Insights</title><link>https://koreainvestinsights.com/tags/micro-contact-solution/</link><description>Recent content in Micro Contact Solution on Korea Invest Insights</description><generator>Hugo -- gohugo.io</generator><language>en</language><copyright>koreainvestinsights.com · @korea_invest_insights</copyright><lastBuildDate>Thu, 15 Oct 2026 23:48:02 +0900</lastBuildDate><atom:link href="https://koreainvestinsights.com/tags/micro-contact-solution/feed.xml" rel="self" type="application/rss+xml"/><item><title>Korea Quality Re-Rating Watch Oct 15: Seegene, HMM — Bear Market Test</title><link>https://koreainvestinsights.com/post/kr-daily-wrap-2026-10-15/</link><pubDate>Thu, 15 Oct 2026 16:30:00 +0900</pubDate><guid>https://koreainvestinsights.com/post/kr-daily-wrap-2026-10-15/</guid><description>&lt;h2 id="macro-dashboard"&gt;Macro Dashboard
&lt;/h2&gt;&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Indicator&lt;/th&gt;
 &lt;th&gt;Level&lt;/th&gt;
 &lt;th&gt;5-Day Change&lt;/th&gt;
 &lt;th&gt;Signal&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSPI&lt;/td&gt;
 &lt;td&gt;5,554&lt;/td&gt;
 &lt;td&gt;−16.2%&lt;/td&gt;
 &lt;td&gt;Bear&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;KOSDAQ&lt;/td&gt;
 &lt;td&gt;761&lt;/td&gt;
 &lt;td&gt;−14.7%&lt;/td&gt;
 &lt;td&gt;Bear&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;VIX&lt;/td&gt;
 &lt;td&gt;17.6&lt;/td&gt;
 &lt;td&gt;+18.7%&lt;/td&gt;
 &lt;td&gt;Stable&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;US 10Y&lt;/td&gt;
 &lt;td&gt;5.19%&lt;/td&gt;
 &lt;td&gt;−0.04pp&lt;/td&gt;
 &lt;td&gt;Flat&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;USD/KRW&lt;/td&gt;
 &lt;td&gt;1,345&lt;/td&gt;
 &lt;td&gt;+0.1%&lt;/td&gt;
 &lt;td&gt;Flat&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;Brent&lt;/td&gt;
 &lt;td&gt;$104.6&lt;/td&gt;
 &lt;td&gt;−1.9%&lt;/td&gt;
 &lt;td&gt;Stable&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;strong&gt;Regime verdict:&lt;/strong&gt; Korea &lt;strong&gt;Bear&lt;/strong&gt; / US &lt;strong&gt;Bull&lt;/strong&gt;. The gap between the two markets is wide and widening. KOSPI has shed more than 1,070 points in five sessions — the price decline is confirmed, but no single macro driver has been identified. Rule-based stance: reduce Korea exposure, maintain US exposure. US breadth (50-day: 25.2%) is also thin, flagging concentration risk in the US rally. Formal review continues at the next scheduled observation.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id="market-wrap"&gt;Market Wrap
&lt;/h2&gt;&lt;p&gt;Thursday&amp;rsquo;s session was a near-total rout. Of 2,591 stocks tracked in the snapshot, 2,199 fell and only 200 advanced — a market breadth reading of 9.1%. The average stock dropped −3.95%. This is not sector rotation or selective risk-off. It is broad-based, indiscriminate selling.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;The worst-hit cohort.&lt;/strong&gt; Small and mid-cap momentum names faced the heaviest institutional exits. The institutional sell list reads like a register of the prior upcycle&amp;rsquo;s winners: 파두 (440110.KQ, −13.75%), 티엘비 (356860.KQ, −15.86%), 엑시콘 (092870.KQ, −12.75%), 로보티즈 (108490.KQ, −12.83%), 두산퓨얼셀 (336260.KS, −13.0%), 브이엠 (089970.KQ, −16.76%), and 인텍플러스 (064290.KQ, −15.16%). Semiconductor equipment, robotics, passive components. Passive component and power cable names — 삼화콘덴서 (001820.KS, −13.4%) and 가온전선 (000500.KS, −13.1%) — were sold simultaneously by both foreigners and institutions, pointing to a coordinated unwind rather than a divergence of views.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Large-cap consumer and industrial weakness.&lt;/strong&gt; Foreigners were net sellers of 삼성물산 (028260.KS, −8.23%), 현대차 (005380.KS, −5.74%), 한화솔루션 (009830.KS, −9.6%), and LG화학 (051910.KS, −5.79%). Retail and department store names fell sharply: 롯데쇼핑 (023530.KS, −8.24%), 신세계 (004170.KS, −7.99%), 현대백화점 (069960.KS, −5.78%). Notably, foreigners were counter-trend net &lt;em&gt;buyers&lt;/em&gt; of the retail group despite the selling — a flow that may reflect value positioning or index mechanics rather than high-conviction directional views.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Where institutions rotated.&lt;/strong&gt; Against the current, institutions accumulated defensives: 삼성바이오로직스 (207940.KS, +5.50%), KB금융 (105560.KS, −1.57%), 신한지주 (055550.KS, −0.84%), 하나금융지주 (086790.KS, +0.66%), and 우리금융지주 (316140.KS, +0.48%). Large-cap financials and biotech were the primary institutional destinations. 삼양식품 (003230.KS, +0.70%) also held with institutional support — a domestic consumer brand finding a bid in a risk-off tape.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Derivatives and passive flows.&lt;/strong&gt; The ETF net creation proxy printed −18,793억 in net redemptions. Arbitrage program buying (+5,138억) partially offset non-arbitrage selling (−430억). Futures open interest jumped +16,159 contracts. Basis remained mildly positive at +0.60. The setup points to futures-led downside pressure with selective institutional accumulation in large-cap defensives and healthcare — not a panic liquidation, but not a buyers&amp;rsquo; market either.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id="todays-quality-re-rating-candidates"&gt;Today&amp;rsquo;s Quality Re-Rating Candidates
&lt;/h2&gt;&lt;p&gt;Today&amp;rsquo;s meta screener ran across 82 tickers and returned 20 ranked candidates. The formal two-screener intersection engine returned zero overlaps today because the PEAD source was last generated on 2026-10-09 (six days old) and was excluded from live overlap calculations. The rankings below use the Meta Screener&amp;rsquo;s multi-evidence family scoring as the primary lens. Where a name also appears in the Oct 9 PEAD screener, that is noted as directional cross-confirmation.&lt;/p&gt;
&lt;table&gt;
 &lt;thead&gt;
 &lt;tr&gt;
 &lt;th&gt;Rank&lt;/th&gt;
 &lt;th&gt;Ticker&lt;/th&gt;
 &lt;th&gt;Name&lt;/th&gt;
 &lt;th&gt;Meta Score&lt;/th&gt;
 &lt;th&gt;Evidence Families&lt;/th&gt;
 &lt;th&gt;Key Screeners Hit&lt;/th&gt;
 &lt;th&gt;Key Metrics&lt;/th&gt;
 &lt;/tr&gt;
 &lt;/thead&gt;
 &lt;tbody&gt;
 &lt;tr&gt;
 &lt;td&gt;1&lt;/td&gt;
 &lt;td&gt;098120.KQ&lt;/td&gt;
 &lt;td&gt;Micro Contact Sol&lt;/td&gt;
 &lt;td&gt;53.6&lt;/td&gt;
 &lt;td&gt;5&lt;/td&gt;
 &lt;td&gt;Quality, Cycle Rerating, Kiwoom&lt;/td&gt;
 &lt;td&gt;ROE 23.1%, OP YoY +73.5%, margin +3.0pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;2&lt;/td&gt;
 &lt;td&gt;204620.KQ&lt;/td&gt;
 &lt;td&gt;Global Tax Free&lt;/td&gt;
 &lt;td&gt;51.8&lt;/td&gt;
 &lt;td&gt;5&lt;/td&gt;
 &lt;td&gt;Quality, RS80 Not-Late, Kiwoom&lt;/td&gt;
 &lt;td&gt;ROE 27.8%, OP YoY +34.3%, inst rank #359&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;3&lt;/td&gt;
 &lt;td&gt;096530.KQ&lt;/td&gt;
 &lt;td&gt;Seegene&lt;/td&gt;
 &lt;td&gt;51.6†&lt;/td&gt;
 &lt;td&gt;5&lt;/td&gt;
 &lt;td&gt;Quality, SmartMoney-Q, Cycle, SmartMoney-E&lt;/td&gt;
 &lt;td&gt;ROE 4.8%, OP YoY +309.7%, margin +11.3pp&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;4&lt;/td&gt;
 &lt;td&gt;011200.KS&lt;/td&gt;
 &lt;td&gt;HMM&lt;/td&gt;
 &lt;td&gt;47.0&lt;/td&gt;
 &lt;td&gt;6&lt;/td&gt;
 &lt;td&gt;SmartMoney-Q, Consensus Up, RS80, Kiwoom&lt;/td&gt;
 &lt;td&gt;F+QI +1,053억/5d, consensus z +0.35&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;5&lt;/td&gt;
 &lt;td&gt;033780.KS&lt;/td&gt;
 &lt;td&gt;KT&amp;amp;G&lt;/td&gt;
 &lt;td&gt;40.0&lt;/td&gt;
 &lt;td&gt;4&lt;/td&gt;
 &lt;td&gt;Quality, RS80 Not-Late, Kiwoom&lt;/td&gt;
 &lt;td&gt;ROE 11.7%, OP YoY +13.0%, foreign ownership 51%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;6&lt;/td&gt;
 &lt;td&gt;018670.KS&lt;/td&gt;
 &lt;td&gt;SK Gas&lt;/td&gt;
 &lt;td&gt;37.8&lt;/td&gt;
 &lt;td&gt;5&lt;/td&gt;
 &lt;td&gt;Cycle Rerating, RS80, Kiwoom&lt;/td&gt;
 &lt;td&gt;OP YoY +54.2%, margin +1.7pp, buyback + IR event&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;7&lt;/td&gt;
 &lt;td&gt;003350.KS&lt;/td&gt;
 &lt;td&gt;Korea Cosmetics Mfg&lt;/td&gt;
 &lt;td&gt;37.3&lt;/td&gt;
 &lt;td&gt;4&lt;/td&gt;
 &lt;td&gt;Quality, Cycle, Kiwoom&lt;/td&gt;
 &lt;td&gt;ROE 30.6%, OP YoY +24.2%, ⚠ DART risk filings ×3&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;8&lt;/td&gt;
 &lt;td&gt;089860.KS&lt;/td&gt;
 &lt;td&gt;Lotte Rental&lt;/td&gt;
 &lt;td&gt;35.6&lt;/td&gt;
 &lt;td&gt;5&lt;/td&gt;
 &lt;td&gt;Cycle, RS80, Kiwoom&lt;/td&gt;
 &lt;td&gt;margin +0.5pp, shareholder meeting filed today&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;9&lt;/td&gt;
 &lt;td&gt;021240.KS&lt;/td&gt;
 &lt;td&gt;Coway&lt;/td&gt;
 &lt;td&gt;34.2&lt;/td&gt;
 &lt;td&gt;4&lt;/td&gt;
 &lt;td&gt;Quality, RS80, Kiwoom&lt;/td&gt;
 &lt;td&gt;ROE 17.1%, OP YoY +10.5%, short interest 14.9%&lt;/td&gt;
 &lt;/tr&gt;
 &lt;tr&gt;
 &lt;td&gt;10&lt;/td&gt;
 &lt;td&gt;131290.KQ&lt;/td&gt;
 &lt;td&gt;TSE&lt;/td&gt;
 &lt;td&gt;33.8&lt;/td&gt;
 &lt;td&gt;4&lt;/td&gt;
 &lt;td&gt;Quality, Kiwoom&lt;/td&gt;
 &lt;td&gt;ROE 10.4%, OP YoY +23.3%, foreign + fintech buying&lt;/td&gt;
 &lt;/tr&gt;
 &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;†Seegene&amp;rsquo;s family score (51.6) compresses its raw score (83.6) because Smart Money Quality and Smart Money Earnings draw from overlapping flow data. The meta engine caps within-family double-counting. By raw signal breadth, Seegene is the widest-coverage name in today&amp;rsquo;s candidate list.&lt;/p&gt;
&lt;hr&gt;
&lt;h3 id="top-3-in-focus"&gt;Top 3 in Focus
&lt;/h3&gt;&lt;p&gt;&lt;strong&gt;씨젠 (096530.KQ) — Seegene.&lt;/strong&gt; The Korean diagnostics company built its franchise on multiplex PCR platforms during the COVID era, then navigated several quarters of post-pandemic revenue normalization. The screener signal today is notable: operating profit rebounded sharply (OP YoY +309.7%, margin expansion +11.3pp), and the recovery is now broad enough to clear four major screener families simultaneously — Quality Compounder, Smart Money Quality (net institutional + foreign flow +64.8억 over 5 days), Smart Money Earnings, and Cycle Rerating. A Q3 interim dividend ex-date DART filing (Oct 28) adds a minor official catalyst. Items to monitor before treating this as a conviction candidate: short interest at 5.9% is not alarming but is present, and a dealer flow anomaly (trading desk flow −14%) signals some positioning overhang. Confirm whether the earnings recovery is broadening across divisions or concentrated in one product line.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;마이크로컨텍솔 (098120.KQ) — Micro Contact Solution.&lt;/strong&gt; The company manufactures semiconductor test contacts and sockets — a small but operationally leveraged niche within the semiconductor supply chain. ROE of 23.1% and OP growth of +73.5% YoY place it firmly in Quality Compounder territory. The Cycle Rerating screen adds margin expansion confirmation (+3.0pp). Kiwoom market surface data shows foreign and quality-institutional buyers absorbing retail supply (−125억 in retail net selling). Notably, the name also appears in the PEAD Tier A list from Oct 9 (ranked 6th), cross-confirming the underlying earnings trend. One DART filing is on record (insider ownership report, Oct 8) — routine and non-material. On a broad sell-off day, holding up with institutional absorption is a meaningful relative signal.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;HMM (011200.KS).&lt;/strong&gt; Korea&amp;rsquo;s largest container shipping company carries the most evidence families of any candidate today — six. The anchoring signal is Smart Money Quality: net foreign + quality-institutional buying of +1,052.7억 over five sessions, absorbing retail supply of −1,609.5억. Consensus estimate revision (composite z-score +0.35) suggests analysts are marking up numbers. RS80 Not-Late Leadership confirms the stock sits in a momentum trend without being in late-stage territory (pivot gap +3.5%, box risk −15.7%). Three DART filings arrived today (Oct 15): shareholder meeting notice, record date setting, and a new facility investment announcement. The facility investment filing is the most substantive and warrants a closer read — specifically the implied capex scale, the route/capacity assumptions, and whether the investment signals management confidence in sustained volume or rate conditions. Check before drawing conclusions from the headline.&lt;/p&gt;
&lt;hr&gt;
&lt;p&gt;&lt;em&gt;Data: KR Macro Regime (2026-10-15, 20:20 KST), KR Market Snapshot (2026-10-15), KR Meta Screener (2026-10-15), KR PEAD (2026-10-09 — six days old; treat PEAD cross-references as directional, not same-day confirmed). All candidates are flagged for research and monitoring purposes only. No buy or sell recommendation is implied.&lt;/em&gt;&lt;/p&gt;</description></item></channel></rss>